What is the recommended lisinopril dosage for adults with hypertension, including adjustments for the elderly, renal impairment, or heart failure?

Lisinopril Dosing for Hypertension, Heart Failure, and Special Populations

For hypertension, start lisinopril at 10 mg once daily and titrate to 20-40 mg daily; for heart failure, start at 5 mg once daily (2.5 mg if hyponatremic) and titrate to a target of 20-40 mg daily, with dose reductions required for renal impairment. 1

Hypertension Dosing

Standard Adult Dosing

• The FDA-approved initial dose for hypertension is 10 mg once daily, with a usual maintenance range of 20-40 mg once daily. 1
• Doses up to 80 mg have been studied but provide no additional benefit beyond 40 mg daily. 1
• For patients already on diuretics, reduce the starting dose to 5 mg once daily to minimize risk of symptomatic hypotension. 1

Combination Therapy Strategy

• If blood pressure remains uncontrolled on lisinopril monotherapy at maximum dose (40 mg daily), add a second antihypertensive agent from a different class rather than exceeding the maximum dose. 2
• The 2017 ACC/AHA guidelines recommend initiating two-drug therapy in patients with stage 2 hypertension (BP >20/10 mm Hg above target), either as separate agents or fixed-dose combinations. 3
• When adding a diuretic, use low-dose hydrochlorothiazide (12.5 mg), which may allow reduction of the lisinopril dose. 1

Heart Failure Dosing

Initial and Target Dosing

• Start at 5 mg once daily for heart failure patients on diuretics and/or digoxin, with a target dose of 20-40 mg once daily. 1
• For patients with hyponatremia (serum sodium <130 mEq/L), start at 2.5 mg once daily. 1
• The American College of Cardiology recommends targeting 20-40 mg once daily for heart failure with reduced ejection fraction (HFrEF). 4

Evidence-Based High-Dose Strategy

• The ATLAS trial demonstrated that high-dose lisinopril (32.5-35 mg daily) reduced death or hospitalization by 12% and heart failure hospitalizations by 24% compared to low-dose therapy (2.5-5 mg daily). 4, 5, 6
• The European Society of Cardiology recommends aiming for target doses of 30-35 mg once daily in heart failure patients for optimal mortality benefit. 4
• At minimum, achieve 50% of the target dose (10 mg daily) for clinical benefit. 4

Titration Protocol

• Increase doses at intervals of not less than 2 weeks. 4
• Titrate to the target dose or, if not tolerated, the highest tolerated dose. 4
• Initial hypotension after the first dose does not preclude careful subsequent titration. 1

Renal Impairment Adjustments

Dose Modifications by Creatinine Clearance

• No adjustment needed for CrCl >30 mL/min. 1
• For CrCl 10-30 mL/min: Start at half the usual dose (5 mg for hypertension, 2.5 mg for heart failure), titrate to maximum 40 mg daily. 1
• For hemodialysis or CrCl <10 mL/min: Start at 2.5 mg once daily. 1
• Dose adjustment prevents drug accumulation while maintaining therapeutic efficacy and ACE inhibition. 7

Monitoring in Renal Impairment

• An increase in creatinine up to 50% above baseline is acceptable and expected when initiating or uptitrating ACE inhibitors. 4
• Monitor blood chemistry (urea, creatinine, potassium) and blood pressure within 5-7 days after initiation or dose increases. 4
• Continue monitoring at 3 months, then every 6 months during maintenance therapy. 4

Elderly Patients

Efficacy and Dosing

• Lisinopril is equally or more effective in elderly patients (≥65 years) compared to younger patients, despite lower renin levels typically seen with aging. 8, 9
• The usual dosage range of 2.5-40 mg/day is effective in elderly patients. 8
• Exercise caution when initiating therapy with two drugs in older adults due to increased risk of hypotension and orthostatic hypotension; monitor blood pressure carefully. 3

Special Considerations

• Lower starting doses may be necessary in elderly patients, particularly those with renal impairment or on diuretics. 10
• The stepped-care approach (single agent with sequential titration) is reasonable in older adults at risk for hypotension. 3

Acute Myocardial Infarction

Post-MI Protocol

• In hemodynamically stable patients, give 5 mg orally within 24 hours of symptom onset, followed by 5 mg at 24 hours, 10 mg at 48 hours, then 10 mg once daily for at least 6 weeks. 1
• For low systolic BP (≤120 mm Hg and >100 mm Hg) during the first 3 days: Start at 2.5 mg. 1
• If hypotension occurs (SBP ≤100 mm Hg), reduce to 5 mg daily maintenance with temporary reductions to 2.5 mg if needed. 1
• Withdraw lisinopril if prolonged hypotension occurs (SBP <90 mm Hg for >1 hour). 1

Critical Monitoring and Safety

Acceptable Changes During Titration

• Asymptomatic hypotension does not require dose reduction. 4, 5
• If symptomatic hypotension occurs, consider reducing diuretic dose before lowering lisinopril dose. 4
• Creatinine elevation up to 50% above baseline is acceptable and does not require discontinuation. 4, 5

Serious Adverse Effects Requiring Action

• Angioedema is a life-threatening reaction warranting permanent discontinuation of all ACE inhibitors. 4
• Monitor potassium levels closely, especially when combined with potassium-sparing diuretics or supplements. 4
• ACE inhibitor-induced cough occurs in up to 20% of patients but rarely requires discontinuation. 4, 5

High-Risk Situations for Acute Renal Failure

• ACE inhibitors can cause reversible acute renal failure in volume-depleted patients, those with bilateral renal artery stenosis, or severe heart failure. 11, 12
• Acute renal failure is most likely in elderly patients with unexpected dehydration from diuretics or gastrointestinal losses. 11
• This complication is reversible after drug withdrawal, even when dialysis is required. 11

Common Pitfalls to Avoid

• The most common error is using subtherapeutic doses—always titrate to target doses for maximum benefit. 5
• Do not exceed 40 mg once daily; higher doses provide no additional efficacy and increase adverse effects. 2, 1
• Never use lisinopril twice daily dosing—it is designed for once-daily administration. 2
• Mild hyperkalemia should be managed with dietary modification and medication adjustment before discontinuing the ACE inhibitor. 5
• In heart failure patients requiring additional renin-angiotensin system blockade, add an aldosterone antagonist (spironolactone) rather than exceeding maximum lisinopril dose. 2